Treatment of injection-induced ecchymoses with light/laser-assisted technology.
IPL
ecchymosis
oxyhemoglobin and deoxyhemoglobin
pulsed dye laser
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
06
10
2018
revised:
02
02
2019
accepted:
10
02
2019
pubmed:
14
2
2019
medline:
15
1
2020
entrez:
14
2
2019
Statut:
ppublish
Résumé
An increasing number of minimally invasive cosmetic procedures, such as filler or botulinum toxin injections, are performed annually. These procedures are associated with a high risk of post-procedure bruising or ecchymosis. Ecchymoses arise following hemorrhage and extravasation of red blood cells into the subcutaneous tissue, leading to local skin discoloration. Although ecchymoses generally resolve within 14 days, their appearance is cosmetically bothersome, and they may be painful and cause major distress to patients. Recent clinical evidence suggests that light/laser technology with pulsed dye laser (PDL) or intense pulsed light (IPL) can dramatically alleviate and minimize bruising when delivered within 24-72 hr of the injection. This article, will review reports of treatment of ecchymosis by lasers and IPL.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e12861Informations de copyright
© 2019 Wiley Periodicals, Inc.